Cohance Lifesciences — Peer Comparison

How the peer fair value is calculated and which companies were used as benchmarks.

Peer selection

Peers are selected from the same Contract research & manufacturing industry. 8 companies were matched as valid comparables.

Same-industry peers share similar business models, cost structures, and growth prospects — making them the most appropriate benchmarks for valuation multiples.

Peer comparison table

Contract research & manufacturing · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Cohance Lifesciences COHANCE · you	₹17,489 Cr	97.7×	4.5×	44.1×	4.6%	7.9%	19.2%
Sector median	—	58.5×	8.5×	37.6×	15.4%	17.0%	10.8%
Laurus Labs LAURUSLABS	₹76,900 Cr	85.5×	14.3×	43.4×	16.8%	13.0%	4.1%
Anthem Biosciences ANTHEM	₹43,836 Cr	74.1×	14.3×	54.2×	19.5%	27.9%	26.2%
Sai Life Sciences SAILIFE	₹26,076 Cr	74.8×	10.5×	41.9×	14.0%	15.9%	21.7%
Neuland Laboratories NEULANDLAB	₹22,034 Cr	60.6×	11.8×	38.6×	19.4%	18.0%	19.3%
Granules India GRANULES	₹18,955 Cr	31.3×	3.7×	16.4×	11.7%	11.1%	5.9%
Syngene International SYNGENE	₹18,242 Cr	56.5×	3.7×	20.2×	6.5%	8.5%	5.4%
Caplin Point Laboratories CAPLIPOINT	₹17,160 Cr	25.1×	4.5×	22.6×	17.9%	29.3%	14.2%
Concord Biotech CONCORDBIO	₹13,302 Cr	51.3×	6.6×	36.5×	12.9%	24.7%	7.3%

Peer comparison verdict

Cohance trades at a premium to sector peers on P/E (97.7× vs median 58.5×). The market is pricing in higher growth — worth verifying whether recent revenue trends support that expectation.

How the peer fair value is calculated

Three valuation methods are weighted by sector. Each gives a fair value based on how sector peers are currently priced.

Method breakdown

40% weight · 7 peers

Sector median PE56.5×

Fair value via PE₹265

20% weight · 8 peers

Sector median PB8.5×

Fair value via PB₹870

EV/EBITDA

40% weight · 8 peers

Sector median EV/EBITDA37.6×

Fair value via EV/EBITDA₹390

Blended peer fair value₹436

Why median? Why these weights?

Median over mean: The sector median is used instead of the average because valuation multiples have extreme outliers — one high-growth company at 200× P/E would dramatically skew a mean. The median gives the middle value in the peer set, which better represents typical pricing.

Sector-specific weights: The weight given to each method reflects what matters most in this sector. For banks, P/B dominates because their value is tied to book assets. For IT companies, P/E carries the most weight because earnings quality matters more than asset base. For capital-intensive businesses, EV/EBITDA accounts for varying debt levels across peers and removes financing structure bias.

Limitations of peer comparison

Peer comparison assumes comparable companies are truly comparable — which is never perfectly true. Sector classifications can be imperfect: a conglomerate classified as "IT" may also have significant manufacturing revenue. Small peer counts (below 5) reduce confidence, as a single outlier can skew the sector median. When the entire sector is broadly expensive, peer comparison will show even an expensive stock as "fairly valued" relative to its peers.

The peer fair value shown is an algorithmic estimate based on publicly available financial data. It is not investment advice or a recommendation to buy, sell, or hold any security. Please consult a SEBI-registered investment adviser before making any investment decision.